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Abstract
The yeast Rgt1 repressor is a bifunctional protein that acts as a transcriptional repressor and
activator. Under glucose-limited conditions, Rgt1 induces transcriptional repression by forming a
repressive complex with its corepressors Mth1 and Std1. Here, we show that Rgt1 is converted
from a transcriptional repressor into an activator under high glucose conditions and this occurs
through two independent but consecutive events mediated by two glucose signaling pathways: (1)
disruption of the repressive complex by the Rgt2/Snf3 pathway; (2) phosphorylation of Rgt1 by
the cAMP-PKA (cAMP-dependent protein kinase) pathway. Rgt1 is phosphorylated by PKA at
four serine residues within its amino-terminal region, but this does not occur until the repressive
complex is disrupted. While phosphorylation of any one of these sites is sufficient to enable Rgt1
to induce transcriptional activation, phosphorylation of all the sites results in the release of Rgt1
from DNA. We discuss how the bifunctional properties of Rgt1 are regulated through differential
phosphorylation.
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Introduction
Glucose sensing and signaling in the budding yeast Saccharomyces cerevisiae represents an
important paradigm for understanding how extracellular signals lead to changes in the gene
expression program in eukaryotes. Due to their specialized mode of glucose metabolism—
aerobic fermentation, yeast cells must pump large amounts of glucose to supply sufficient
ATP via glycolysis. To accomplish this, yeast cells enhance expression of the glucose
transporter genes (HXT) when glucose is available in their environment. Glucose-induction
of HXT expression is largely regulated by Rgt1, a member of the Gal4-family of
transcription factors that contains a Zn2Cys6 binuclear cluster DNA-binding domain (Ozcan
and Johnston, 1995; Ozcan et al., 1996; Kim et al., 2003; Kim, 2004; Kim, 2009). Under
glucose-limited conditions, Rgt1 recruits the general corepressor complex Ssn6-Tup1, which
mediates repression of many genes, to the HXT promoters (Kim et al., 2003; Ozcan and
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Johnston, 1995). Rgt1 does this in conjunction with its corepressors Mth1 and Std1,
paralogous proteins that interact with Rgt1 (Tomas-Cobos et al., 2002; Lakshmanan et al.,
2003; Polish et al., 2005). Furthermore, chromatin immunoprecipitation analyses show that
Mth1 and Std1 are associated with the HXT3 promoter along with Ssn6 and Tup1,
suggesting that Rgt1 forms a protein complex with these proteins to inhibit transcription of
the HXT genes (Kim et al., 2003).
The presence of extracellular glucose appears to cause a disruption of the protein complex
(Flick et al., 2003; Moriya and Johnston, 2004; Kim et al., 2006). Mth1 and Std1 are subject
to glucose-dependent degradation through phosphorylation-mediated ubiquitination (Flick et
al., 2003; Kim et al., 2006). In this process, Mth1 and Std1 are phosphorylated by the
plasma membrane-tethered yeast casein kinases (Yck1/2) (Moriya and Johnston, 2004) and
ubiquitinated by the SCFGrr1 ubiquitin ligase (Spielewoy et al., 2004). The resulting
ubiquitinated Mth1 and Std1 are then targeted for degradation by the 26S proteasome. It is
not clearly understood how Yck1/2 are activated in response to glucose (Pasula et al., 2010),
but the kinases have been shown to interact with the two plasma membrane-spanning
glucose sensors Rgt2 and Snf3 (Moriya and Johnston, 2004), which are activated upon
glucose binding (Ozcan et al., 1996). Therefore, it has been proposed that the glucose
sensors trigger a signaling pathway in response to glucose that ultimately alters the function
of Rgt1 in the nucleus (Ozcan et al., 1998; Pasula et al., 2007).
It has been also shown that Rgt1 function is regulated by PKA. Induction of HXT1 is
prevented in cells with attenuated PKA activity (Kim and Johnston, 2006; Palomino et al.,
2006) or cells expressing Rgt1 without the putative PKA phosphorylation sites in Rgt1 (Kim
and Johnston, 2006). Genome-wide expression profiling has also shown that the cAMP-
PKA pathway is involved in the regulation of HXT expression (Wang et al., 2004; Zaman et
al., 2009). These findings lead us to posit that the two glucose signaling pathways—the
Rgt2/Snf3 pathway and the cAMP-PKA pathway—collaborate to suppress the repressor
function of Rgt1 (Kim and Johnston, 2006).
Rgt1 also acts as a transcriptional activator. Unlike other HXT genes such as HXT3,
glucose-induced expression of HXT1 is ∼ 6-fold decreased in the rgt1 mutant (Ozcan and
Johnston, 1995). In addition, a LexA-Rgt1 fusion strongly activates transcription of the
CYC1-lacZ reporter gene that contains a lexO site (Ozcan et al., 1996; Polish et al., 2005).
Also, Rgt1 is converted from a transcriptional repressor to an activator upon glucose-
mediated phosphorylation (Mosley et al., 2003). However, the underlying mechanism of this
conversion is still unclear. In this study, we examined how the bifunctional Rgt1 repressor is




Except where indicated, yeast strains were grown in YP (2% bacto-peptone, 1% yeast
extract) or SYNB (synthetic yeast nitrogen base media; 0.17% yeast nitrogen base with
0.5% ammonium sulfate) supplemented with the appropriate amino acids. The yeast strains
used were BY4742 (MATα his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 (Brachmann et al., 1998)),
YM6370 (BY4742 rgt2∷kanMX snf3∷kanMX (Kaniak et al., 2004)), DC124 (MATa his3
leu2 ura3 trp1 ade8 (Cameron et al., 1988), and RS-13-58A-1 (MATa his3 leu2 ura3 trp1
ade8 tpk1w1 tpk2∷HIS3 tpk3∷TRP1 bcy1∷LEU2 (Cameron et al., 1988).
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Western blotting was performed as described previously (Kim et al., 2003). Briefly, 5 ml of
yeast cells (O.D600=1.2∼1.5) expressing GFP-Mth1 were collected by centrifugation at
3,000 rpm in a table-top centrifuge for 5 min, and the cell pellets were resuspended in 100
μl of SDS-buffer (50 mM Tris-HCl, pH 6.8, 10% glycerol, 2% SDS, 5% β-mercaptoethanol)
and boiled for 5 min. After the lysates were cleared by centrifugation at 12,000 rpm for 10
min., soluble proteins were resolved by SDS-PAGE and transferred to PVDF membrane
(Millipore). The membrane was incubated with anti-GFP-antibody in TBST buffer (10 mM
Tris-HCl, pH 7.5, 150mM NaCl, 0.05% Tween-20) and proteins were detected by the
enhanced chemiluminescence (ECL) system (Pierce).
Chromatin Immunoprecipitation (CHIP)
ChIP was carried out as described previously (Kim et al., 2003). Yeast cells expressing HA-
Rgt1 were grown to mid-log phase (OD600 = 1.0∼1.2) and incubated with formaldehyde
(1% final concentration) for 15 to 20 min at room temperature. The cross-linking reaction
was quenched by adding glycine to a final concentration of 125 mM for 5 min. The cells
were disrupted by vortexing with glass beads in lysis buffer (50 mM HEPES, pH 7.5, 150
mM NaCl, 1% Triton X-100, 0.1% Na-deoxycholate). The lysate was sonicated (ultrasonic
cell disruptor with a microtip) five times with 10-s pulses. The genomic DNA fragments,
which averaged 200 to 500 bp in length, were immunoprecipitated with the monoclonal HA
antibody (Santa Cruz). The immunoprecipitated DNA and 1/100 of the input DNA were
used as templates in a 25-cycle PCR. The sequences of primer pairs used for ChIP of the
HXT1 gene promoters were 5′ATATAATTCCCCCCTCCTGAAG-3′ and 5′-
TGATTCTACGTTTTTGCAAG C -3′.
Fluorescence Microscopy
Cells expressing GFP-fluorescent proteins were visualized using a Zeiss LSM 510 META
confocal laser scanning microscope with a 63× Plan-Apochromat 1.4 NA Oil DIC objective
lens. Images were acquired with the Zeiss LSM 510 software version 3.2.
β-Galactosidase Assay
To assay β-galactosidase activity with yeast cells expressing the HXT1-lacZ reporter, the
yeast cells were grown to mid-log phase and the assay was performed as described
previously (Kaniak et al., 2004). Results were given in Miller Units [(1,000 × OD420)/(T ×
V × OD600), where OD420 was the optical density at 420 nm, T was the incubation time in
minutes, and V is the volume of cells in milliliters]. The reported enzyme activities were
averages of results from triplicates of three different transformants.
Results
Differential Activation of the RGT2/SNF3 and cAMP-PKA Glucose Signaling Pathways by
Different Sugars
To understand the respective roles of the two pathways in glucose-regulation of Rgt1
function, we first attempted to identify sugars that can differentially activate the two
pathways. To this end, we tested 15 sugars for their ability to activate the Rgt2/Snf3
pathway by measuring degradation of Mth1. The sugars tested include glucose, galactose,
mannose, fructose, xylose, sucrose, lactose, maltose, cellobiose, raffinose, arabinose, allose,
talose, isomaltose, and sorbose. Std1, the Mth1 paralog, is also subject to glucose-dependent
degradation, but Std1 degradation is obscured by feedback regulation of glucose-induced
STD1 expression (Kaniak et al., 2004; Kim et al., 2006). For this reason, Std1 was not
thoroughly examined in this study. Mth1 degradation occurs in a glucose-sensor dependent
Jouandot et al. Page 3













manner in only cells grown on glucose, fructose, or mannose (Fig. 1A). In sucrose medium,
Mth1 is degraded in wild type cells but not in the suc2 mutant cells that lack the invertase
activity. Sucrose is a disaccharide that consists of glucose and fructose. Therefore, it is likely
that the glucose sensors in sucrose-fermenting cells were activated by the glucose and
fructose produced by hydrolysis of sucrose, rather than by sucrose itself. Glucose and
galactose only differ with respect to C-4, yet galactose does not activate the glucose sensors,
suggesting that the glucose sensors have remarkable substrate specificity.
Glucose-Dependent Degradation of MTH1 is Required but is Not Sufficient for Induction of
HXT1
Next, we explored whether Mth1 degradation directly results in induction of HXT1 by
measuring expression of the HXT1-lacZ reporter gene (Fig. 1B). Interestingly, HXT1
expression is activated by glucose, but not significantly by fructose and mannose, even
though all of these sugars have equal ability to induce degradation of Mth1 through the
Rgt2/Snf3 pathway (Fig. 1A). Rgt1 proteins expressed in cells grown on glucose, fructose or
mannose are differently phosphorylated (Fig. 1C) and have different binding affinities for
the HXT1 promoter (Fig. 1D). This is perhaps due to different PKA activities in those cells,
because the cAMP-PKA pathway is activated by glucose, but not significantly activated by
fructose and mannose (Rolland et al., 2002).
In yeast, glucose, fructose, and mannose are all taken up by the glucose transporters and
metabolized (Reifenberger et al., 1995), raising the possibility that the sugar metabolites
might affect induction of HXT genes. We examined this possibility by testing whether 2-
deoxy glucose (2-DG), a glucose analog that is transported into the cells but not further
metabolized, can induce expression of HXT1. Mth1 degradation normally occurs in 2-DG-
treated cells in a glucose sensor-dependent manner (Fig. 2A), supporting the idea that
glucose metabolism is not required for activation of the glucose sensors (Ozcan, 2002;
Dietvorst et al., 2010). In those cells, however, neither significant expression of HXT1 (Fig.
2B) nor removal of Rgt1 from the HXT1 promoter is observed (Fig. 2C). In addition, the
characteristic hyperphosphorylation of Rgt1 is not also observed (Fig. 2D). These results
suggest that Rgt1 is not phosphorylated by PKA in those cells, because 2-DG does not
activate the cAMP-PKA pathway (Lemaire et al., 2004).
Since subcellular localization of Msn2, a transcription factor that is activated in stress
conditions, is regulated by PKA-mediated phosphorylation, we examined the localization of
Msn2-GFP in cells grown on the sugars tested above (Fig. 3A). Msn2-GFP (Huh et al.,
2003) is found in the cytoplasm in cells grown in high-glucose medium, as reported
previously (Smith et al., 1998). On the contrary, Msn2-GFP is localized to the nucleus in
cells grown on galactose, mannose, or 2-DG, suggesting that the cAMP-PKA pathway is
activated only by glucose but not the others. Taken together, our results indicate that Mth1
degradation is required but not sufficient for induction of HXT1, because Rgt1 is not
released from the HXT1 promoter until it is phosphorylated by PKA.
The Target of the cAMP-PKA Pathway is the RGT1 Repressor but not its Corepressor
MTH1
Our results above indicate that glucose-induction of HXT1 expression is achieved through
the two glucose-dependent events—the degradation of Mth1 and the release of Rgt1 from
DNA—that are regulated by an interaction between the two glucose signaling pathways. To
gain more insight into these events, we determined whether PKA is also involved in
degradation of Mth1. Our Western blot analysis shows that glucose-induced degradation of
Mth1 normally occurs in the tpkw1 cells with attenuated PKA activity (Fig. 3B). There are
two putative PKA consensus phosphorylation sites ((R-(R/K/S)-X-(S/T), phosphorylatable
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Ser or Thr are underlined (Kennelly and Krebs, 1991)) at Ser-112 and Ser-358 in Mth1.
Changing these serine residues to alanines does not significantly inhibit degradation of Mth1
(Data not shown). Therefore, these results suggest that the cAMP-PKA pathway is not
involved in the degradation of Mth1.
Glucose Induces Hyperphosphorylation of RGT1
Mosley et al. (2003) have shown that glucose-mediated phosphorylation converts Rgt1 from
a transcriptional repressor to an activator. To identify the domains of Rgt1 that are
phosphorylated in response to glucose, three different regions of Rgt1 [1-392 (I), 392-782
(II), and 782-1171 (III)] were isolated from cells grown in medium with or without glucose
and treated with calf intestinal phosphatase (CIP). The mobility of LexA-Rgt1 fragments I
and II are increased upon treatment with CIP, indicating that the changes in mobility are due
to phosphorylation (Fig. 4A). These results are consistent with the previous results showing
that Rgt1 lacking the first 392 amino acids, unlike the full-length Rgt1, does not exhibit the
characteristic phosphorylation-dependent mobility shift upon SDS-PAGE (Mosley et al.,
2003). Therefore, glucose-induced phosphorylation likely occurs in the amino-terminal
region of Rgt1.
To identify phosphorylated amino acid residues, LexA-Rgt1 (1-392) was metabolically
labeled with [32P] in cells grown on galactose or glucose, and harvested using LexA-
antibody conjugated beads. After incubation with trypsin, the tryptic phosphopeptides of
[32P]-labeled LexA-Rgt1 (1-392) were resolved in 2-dimensional gels (Fig. 4B). The
resulting autoradiographs show that there are four major phosphopeptides from galactose
samples (No. 1 - 4) and five from glucose samples (No. 1 - 5) and that there are also several
minor phosphopeptides present only in the glucose samples. These results suggest that the
N-terminal Rgt1 is phosphorylated at multiple sites, and some of which are induced by
glucose.
PKA Catalyzes the Phosphorylation of RGT1 that Converts it from a Transcription
Repressor to an Activator
PKA was initially identified as an Rgt1 kinase by an in vitro phosphorylation assay (Kim
and Johnston, 2006) using 119 known and predicted yeast kinases (Zhu et al., 2000). Rgt1
has 10 putative PKA phosphorylatable Ser residues, 5 of the 10 serines (positions at 146,
202, 283, 284, and 293) are well conserved in yeast. We have previously shown that
changing the serines to alanines fully prevents glucose induction of HXT1 expression (Kim
and Johnston, 2006). To identify the amino acid residues that are crucial for the activator
function of Rgt1, all of these serines were individually mutated to alanines. The resulting
mutant LexA-Rgt1 proteins were tested for transcriptional activation of the CYC1-lacZ
reporter, which contains a lexO site in place of the CYC1 UAS (Ozcan et al., 1996) (Fig.
5A). Our results show that mutations altering Ser-202, Ser-283, or Ser-284 inhibit the Rgt1-
and glucose-dependent transcriptional activation of CYC1-lacZ expression without affecting
Rgt1 stability (Fig. 5B); in contrast, mutation at Ser-146 or at Ser-293 causes only about
25% reduction in expression of the reporter gene.
To make certain that PKA catalyzes phosphorylation of the three serines (Ser-202, Ser-283,
and Ser-284), we examined the in vitro phosphorylation of the mutant Rgt1 (3SA) using
Gst-Tpk1 as described previously (Kim and Johnston, 2006). As shown in Fig. 5C, Gst-
Tpk1 phosphorylates wild-type LexA-Rgt but not alanine-substituted LexA-Rgt1 (3SA).
These results suggest that PKA-mediated phosphorylation of any one of these residues is
sufficient to convert Rgt1 from a transcriptional repressor to an activator.
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Derepression of Rgt1-repressed genes such as the HXT genes is achieved when Rgt1 is
inactivated by disruption of the Rgt1 repressor-corepressor complex through crosstalk
between glucose signaling pathways (Johnston and Kim, 2005). Cellular level of Mth1 is
crucial for regulating Rgt1 function, and is tightly controlled by two mechanisms operating
differently. First, Mth1 is highly regulated at the translational level; it undergoes glucose-
dependent proteasomal degradation triggered by the Rgt2/Snf3 pathway. Second, the MTH1
gene is subject to transcriptional control by the Snf1-Mig1 pathway. Mig1, a downstream
target of Snf1 kinase, binds to the MTH1 promoter and represses transcription of the gene.
These results indicate that the Rgt2/Snf3 and Snf1-Mig1 pathways are intertwined in a
regulatory circuit to reinforce Mth1 degradation by glucose repression of MTH1 (Kaniak et
al., 2004). The present study describes that glucose-induced inactivation of Mth1 is not
sufficient to suppress completely the repressor function of Rgt1. Rgt1 remains bound to the
HXT1 promoter until it is phosphorylated by the cAMP-PKA pathway, which was identified
as the third glucose signaling pathway that regulates Rgt1 function (Kim and Johnston,
2006; Palomino et al., 2006). It now becomes clear that the process to alter Rgt1 function
consists of two consecutive steps: (1) disruption of the Rgt1 repressor-corepressor complex
via degradation of Mth1; (2) phosphorylation-induced release of Rgt1 from DNA.
It is not fully understood why Rgt1 is regulated through these two distinctive steps, but this
may be due in part to the dual function properties of Rgt1 acting as a transcriptional
repressor and activator. The repressor function of Rgt1 is abolished through its
intramolecular interaction (Polish et al., 2005) which occurs in a phosphorylation -dependent
manner (Kim and Johnston, 2006). This process requires removal of Mth1; otherwise, it
sterically hinders the phosphorylation-induced conformational change of Rgt1 by blocking
access of PKA to Rgt1. PKA-mediated phosphorylation likely regulates Rgt1 function via
two different modes; inhibition of its transcriptional repressor function and stimulation of its
activator function. Rgt1 is differentially phosphorylated by PKA at the four putative PKA
sites within its N-terminus. Phosphorylation of any one of the three serines—Ser-202,
Ser-283, and Ser-284—is sufficient to convert Rgt1 to a transcriptional activator (Fig. 5);
phosphorylation at all of these four serines—Ser-146, Ser-202, Ser-283, and Ser-284—
results in a significant decrease in the DNA-binding activity of Rgt1 that leads to the
suppression of its repressor function (Kim and Johnston, 2006). Therefore, the distinctive
bifunctional properties of Rgt1 are conferred by its differential phosphorylation. We surmise
that Rgt1 is readily phosphorylated at any one of these three serines and activates
transcription, and then acts in this manner until it is removed from DNA upon
phosphorylation at all of these four serines. Thus, this model is similar to the ‘hit-and-run’
mechanism as described previously (Cosma et al., 1999; Frolova et al., 1999; Fletcher et al.,
2002). TAF12 (TAF61), a subunit of the TFIID and SAGA complexes, is also associated
with Rgt1 (Sanders et al., 2002), suggesting that Rgt1 can directly activate transcription.
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Mth1 degradation does not directly activate expression of HXT1. (A) Yeast cells (wild type,
rgt2Δsnf3Δ, and suc2Δ) expressing GFP-Mth1 under the control of the glucose-
independent MET25 promoter were grown to mid-log phase (O.D600=1.2∼1.5) in minimal
medium (MM) containing 2% galactose. Aliquots were washed with MM without sugar and
then transferred to MM containing the various sugars (2%) indicated above in each lane.
After incubation at 30°C for 30 min, yeast cell extracts were prepared and resolved by SDS-
PAGE, followed by Western blotting with anti-GFP antibody. (B) Yeast cells expressing
HXT1-lacZ were grown as described in panel (A). Triplicates of three different
transformants were assayed for their β-galactosidase activity in permeabilized cells grown to
mid-log phase. Activities are given in Miller Units. (C) Rgt1-HA proteins were analyzed by
Western blotting using the HA-antibody. (D) Chromatin was precipitated from cells
expressing Rgt1-HA with the anti-HA antibody as described in the Material and Methods
section. The immunoprecipitated DNA and 1/100 of the input DNA (input) were used as
templates for PCR amplification.
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2-DG activates the Rgt2/Snf3 pathway but not the cAMP-PKA pathway. Yeast cells were
grown as described in Fig. 1, and the aliquots of the cells were transferred to MM containing
galactose (Gal), glucose (Glu), or 2-DG (final concentration, 2%). Western blotting (A), β-
galactosidase activity (B), and ChIP (C) assays were carried out as described in Fig. 1. (D)
Immunoprecipitated Rgt1-HA was incubated with 10 U of calf intestinal alkaline
phosphatase (CIP) (Roche) at 37°C for 30 min and analyzed by Western blotting using the
HA antibody.
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PKA is not involved in degradation of Mth1. Yeast cells expressing Msn2-GFP were grown
to mid-log phase under glucose-limiting condition (2% galactose). Aliquots of the cells were
washed with MM and further incubated in MM containing the various sugars (final
concentration, 2%) indicated above each lane. Localization of Msn2-GFP was examined by
fluorescent microscopy. Rgt1, a nuclear protein (Kim et al., 2003), was used as a control.
(B) GFP-Mth1 was expressed in wild type cells or cells carrying the tpkw1 allele
(bcy1tpk1w1tpk2tpk3) that encodes a functionally attenuated PKA catalytic subunit and
analyzed by Western blotting using the GFP antibody as described in Fig. 1.
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Glucose-induced Rgt1 phosphorylation occurs at its amino-terminal region. (A) Different
domains of LexA-Rgt1 [1-392 (I), 392-782 (II), and 782-1171 (III)] were expressed in yeast
cells grown in galactose- or glucose-containing medium. The proteins were harvested with
the anti-LexA antibody-conjugated beads. The immunoprecipitated proteins were incubated
with (+) and without (-) 10 U of calf intestinal alkaline phosphatase (CIP) (Roche) for 30
min and then subjected to Western blotting with the anti-LexA antibody (Santa cruz). (B)
Tryptic phosphopeptide analysis of [32P]-labeled LexA-Rgt1. LexA-Rgt1 (1-392) were
labeled with [32P] orthophosphate in yeast cells grown on galactose or glucose.
Radiolabeled proteins were immunoprecipitated with the LexA antibody-conjugated beads
and digested with trypsin. Tryptic phosphopeptides were analyzed on thin layer cellulose
plates by electrophoresis followed by chromatography, and phosphopeptides were visualized
by autoradiography.
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PKA-mediated phosphorylation at either Ser-202, Ser-283, or Ser-284 is sufficient for
converting Rgt1 from a transcriptional repressor to an activator. (A) The serines in the 10
potential PKA phosphorylation sites in Rgt1 were changed to alanines, and the mutant Rgt1
proteins were tested for their ability to activate transcription of the CYC1-lacZ reporter.
Cells were grown in MM-galactose to the mid-log phase and transferred to MM-glucose
medium. β-galactosidase activity was assayed as described in Fig. 1. (B) Levels of some of
mutant Rgt1 proteins (S202A, S283A, S284A, and 3SA) were analyzed by Western blotting
with the anti-LexA antibody. (C) In vitro phosphorylation of LexA-Rgt1 by Tpk1. The wild-
type LexA-Rgt1, LexA-Rgt1 (3SA) with the three serines substituted for alanines (S202A,
S283A, and S284A), and Gst-Tpk1 were affinity-purified using the LexA-beads and Gst-
beads, respectively. Gst-Tpk1 proteins were incubated with (+) or without (-) the LexA-Rgt1
proteins in buffer containing [32P] ATP for 30 min and resolved by SDS-PAGE and detected
by autoradiography.
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